Evidence map›Paper›PMID 40294360›Full record

ArticleJCO global oncology2025

Improving the Sensitivity-Specificity Balance of Human Papillomavirus Testing on Self- and Clinician-Collected Samples in South Africa.

Gbenankpon M Houvessou, Rakiya Saidu, Rosalind Boa, Nomonde Mbatani, Jennifer Moodley, Louise Kuhn

Abstract read
In one paragraph

Article in JCO global oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gbenankpon M HouvessouGertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY.
Rakiya SaiduDepartment Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Rosalind BoaDepartment Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Nomonde MbataniDepartment Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-8826-5182
Jennifer MoodleyDepartment Obstetrics and Gynaecology, Faculty of Health Sciences, South African Medical Research Council Gynaecology Cancer Research Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-9398-5202
Louise KuhnGertrude H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-2305-8665

Funding

The Empilisweni Initiative - Advancing Implementation of Cervical Cancer ControlU54CA284030 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DELIVETTE CASTOR · 2023 to 2026
$5.2M
Automated Digital Imaging for Cervical Cancer ScreeningR01CA254576 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUHN, LOUISE · 2020 to 2024
$2.6M
Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive WomenR01CA250011 · NCI · UNIVERSITY OF CAPE TOWN · PI KUHN, LOUISE, MBATANI, NOMONDE HAZEL · 2020 to 2024
$1.7M
National Cancer Institute (NCI) UH2/3 CA189908NCI NIH HHS R01 CA250011NCI NIH HHS R01 CA254576NCI NIH HHS U54 CA284030
6 · The paper itself

Abstract

purposeHuman papillomavirus (HPV) testing on self-collected samples may increase coverage of cervical cancer screening, but previous studies have observed lower specificity of HPV testing in self- versus clinician-collected samples. Here we investigate strategies to improve the sensitivity-specificity balance of a round of HPV testing on self-collected samples. MATERIALS AND

methodsWomen living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that detects the 14 high-risk HPV types in five separate channels: (P1) HPV 16; (P2) HPV 18, 45; (P3) HPV 31, 33, 35, 52, 58; (P4) HPV 51, 59; and (P5) HPV 39, 56, 66, 68. All women underwent colposcopy with histology sampling, and diagnosis of cervical intraepithelial neoplasia grade 2 or greater (CIN2+) was determined by adjudicated pathology. The AUC and related performance parameters were calculated using logistic regression with the cycle threshold (Ct) values of the channels as predictors.

resultsHPV prevalence in women without and with HIV was higher in self-collected (25.1%

conclusionUsing more stringent Ct cutoffs on the three channels that detect the eight highest-risk HPV types can improve the sensitivity-specificity balance of a round of screening in both self- and clinician-collected samples. Although performance of HPV testing on self-collected samples is excellent, performance parameters are better on clinician-collected samples.

Indexed as

PapillomaviridaePapillomavirus InfectionsSpecimen HandlingUterine Cervical DysplasiaUterine Cervical NeoplasmsAdultAgedEarly Detection of CancerFemaleHuman Papillomavirus VirusesHumansMiddle AgedSensitivity and SpecificitySouth AfricaVaginal Smears

Identifiers

PMID40294360
PMCPMC12056977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.